AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis
AgNovos Bioscience has raised $31.5M in total funding. The most recent round was Series B. The last funding was announced in June 2023.
AgNovos Bioscience is headquartered in New York, United States.
AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis
AgNovos Bioscience is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AgNovos Bioscience — Funding & Investors." VCBacked, June 9, 2023, https://www.vcbacked.co/company/agnovos-bioscience. Accessed August 14, 2026.
VCBacked. (2023). AgNovos Bioscience — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/agnovos-bioscience
{{cite web |title=AgNovos Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/agnovos-bioscience |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated